Login
$BBIO
$77.40 -$0.90 (1.15%) Live

Company Executives

Officer Age In this role 2025 pay Source
Neil Kumar Also a director
Chief Executive Officer and Director
47 Not stated $14,944,585
Thomas Trimarchi
President and Chief Financial Officer
41 Since 2025
1 year
$5,832,369
Maricel Apuli
Chief Accounting Officer
Title from the Form 4 dated Oct 30, 2026
Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 24, 2026 · updated by the 8-K of Jun 26, 2026

Directors
13
serving now
Independent
10 of 13
stated in the proxy
Average tenure
6.8 years
from year joined
Director Age On board Independent Committees Other public boards 2025 pay Source
Neil Kumar
47 2015
11 years
Not independent None stated Maze Therapeutics, Inc. Paid as CEO
Fred Hassan
80 2021
5 years
Independent None stated EyePoint Pharmaceuticals, Inc. $599,947
Eric Aguiar
64 2019
7 years
Independent
Audit Committee
Biomea Fusion, Inc. $599,947
Jennifer E. Cook
60 2019
7 years
Independent
Compensation Committee
Denali Therapeutics, Inc. $599,947
Douglas A. Dachille
61 2021
5 years
Independent
Audit Committee
Equitable Holdings, Inc. $599,947
Ronald J. Daniels
66 2020
6 years
Independent
Compensation Committee
None stated $599,947
Andrea J. Ellis
40 2021
5 years
Independent None stated None stated $599,947
Charles Homcy
77 2018
8 years
Not independent None stated Maze Therapeutics, Inc. $1,124,114
Andrew W. Lo
65 2020
6 years
Independent
Nominating and Corporate Governance Committee
G-CAR, n-Lorem, Vesalius Therapeutics, Uncommon Cures Not stated
Frank P. McCormick
75 2023
3 years
Not independent None stated BridgeBio Oncology Therapeutics, Inc. Not stated
James C. Momtazee
54 2016
10 years
Independent None stated Roivant Sciences, Inc. $599,947
Ali J. Satvat
48 2016
10 years
Independent None stated Coherus Oncology, Inc. $599,947
Hannah A. Valantine
74 2021
5 years
Independent
Nominating and Corporate Governance Committee
Pacific Biosciences of California, Inc. $599,947

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 24, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support